Stock Events

Stock Events

Terns Pharmaceuticals (430.F) Q2 2024 Earnings

13MayConfirmed

Q4 2023

Q2 2024

-0.32

-0.3

-0.28

-0.27

Details

Expected EPS

-0.32099659912

Actual EPS

-0.27794399999999997

Surprise EPS

0.04

Surprise Percent

+13.41%

Description

Terns Pharmaceuticals (430.F) has reported earnings of -0.27794399999999997 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.